BSECompany Update6 Oct 2026 · 6 Oct 2026, 05:27 pm
The Exchange has sought clarification from Shukra Pharmaceuticals Ltd on October 06, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
Shukra Pharmaceuticals Ltd · 524632
✦ AI SummaryRegulatory
The BSE has sought clarification from Shukra Pharmaceuticals Ltd regarding significant price movement, to ensure investors have relevant information and safeguard their interests.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shukra Pharmaceuticals Ltd - 524632 - Clarification sought from Shukra Pharmaceuticals Ltd